Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian public health system

OBJECTIVE: This work aims to analyze the quantity and expenses related to biological drugs used for the treatment of rheumatoid arthritis (RA) in outpatient public care within the Brazilian Unified Health System (SUS). METHODS: It is a cross-sectional descriptive study based on secondary data from a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mega, Tacila Pires, da Silva, Rondineli Mendes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355319/
https://www.ncbi.nlm.nih.gov/pubmed/37556663
http://dx.doi.org/10.11606/s1518-8787.2023057004280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355319/
https://www.ncbi.nlm.nih.gov/pubmed/37556663
http://dx.doi.org/10.11606/s1518-8787.2023057004280

Ejemplares similares